Pyrimethamine
6 NDCs across 4 manufacturers|6 Generic,0 Brand
Pyrimethamine is used to treat aids-related opportunistic infections, falciparum malaria and toxoplasmosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Feb 28, 2020. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $8 million on Pyrimethamine across 515 claims for 112 beneficiaries.
Pyrimethamine is available as 6 NDCs from 4 manufacturers (6 generic, 0 brand), with NADAC prices from $137.01 to $137.01 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
6G / 0B
Manufacturers
4
competing in market
Price Spread
$137.01 – $137.01
per EA
7d Activity
avg +0.0% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Dr. Reddy's Laboratories Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Dihydrofolate Reductase Inhibitor Antimalarial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing PYRIMETHAMINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PYRIMETHAMINE 25 MG TABLET | $137.0088 per EA | — |
PYRIMETHAMINE 25 MG TABLET | $137.0088 per EA | — |
PYRIMETHAMINE 25 MG TABLET | $137.0088 per EA | — |
PYRIMETHAMINE 25 MG TABLET | $137.0088 per EA | — |
PYRIMETHAMINE 25 MG TABLET | $137.0088 per EA | — |
PYRIMETHAMINE 25 MG TABLET | $137.0088 per EA | — |
Frequently Asked Questions
What is Pyrimethamine used to treat?
Pyrimethamine is used to treat aids-related opportunistic infections, falciparum malaria and toxoplasmosis, per the National Library of Medicine's MED-RT classification.
When did Pyrimethamine become available as a generic?
FDA approved the first generic Pyrimethamine (ANDA) on Feb 28, 2020. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Pyrimethamine?
In 2024, Medicare Part D spent $8 million on Pyrimethamine across 515 claims for 112 beneficiaries.
How many Pyrimethamine products are on the market?
The Pyrimethamine drug market contains 6 NDCs from 4 manufacturers — 6 generic and 0 brand products.
What is the price range for Pyrimethamine?
NADAC reference prices for Pyrimethamine range from $137.0088 to $137.0088 per EA.
Which manufacturers make Pyrimethamine?
4 manufacturers list Pyrimethamine in NADAC. Ranked by number of NDCs, the largest are Dr. Reddy's Laboratories Inc. (2), Teva Pharmaceuticals USA Inc. (2), Aurobindo Pharma Limited (1), NorthStar Rx LLC (1).